Zimmer Intangible Assets from 2010 to 2026

ZBH Stock  USD 98.13  0.98  1.01%   
Zimmer Biomet's Intangible Assets are increasing with slightly volatile movements from year to year. Intangible Assets are predicted to flatten to about 4 B. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
2003-06-30
Previous Quarter
4.7 B
Current Value
4.7 B
Quarterly Volatility
3.1 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 553.6 M, Interest Expense of 151.7 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 2.05, Dividend Yield of 0.0151 or PTB Ratio of 1.33. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Build AI portfolio with Zimmer Stock
Check out the analysis of Zimmer Biomet Correlation against competitors.
The Intangible Assets trend for Zimmer Biomet Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Zimmer Biomet is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Zimmer Biomet's Intangible Assets Growth Pattern

Below is the plot of the Intangible Assets of Zimmer Biomet Holdings over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Zimmer Biomet's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
Intangible Assets10 Years Trend
Slightly volatile
   Intangible Assets   
       Timeline  

Zimmer Intangible Assets Regression Statistics

Arithmetic Mean4,876,699,974
Geometric Mean3,563,013,564
Coefficient Of Variation60.03
Mean Deviation2,326,764,730
Median4,856,400,000
Standard Deviation2,927,485,857
Sample Variance8570173.4T
Range8.5B
R-Value0.35
Mean Square Error8044922.9T
R-Squared0.12
Significance0.17
Slope200,788,472
Total Sum of Squares137122775.1T

Zimmer Intangible Assets History

2026B
20254.7 B
20244.6 B
20234.9 B
20225.1 B
20215.5 B
20207.1 B

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's Intangible Assets, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Intangible Assets4.7 BB

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is there potential for Health Care Equipment & Supplies market expansion? Will Zimmer introduce new products? Factors like these will boost the valuation of Zimmer Biomet. Anticipated expansion of Zimmer directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.41)
Dividend Share
0.96
Earnings Share
3.55
Revenue Per Share
41.573
Quarterly Revenue Growth
0.109
Zimmer Biomet Holdings's market price often diverges from its book value, the accounting figure shown on Zimmer's balance sheet. Smart investors calculate Zimmer Biomet's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zimmer Biomet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.